EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy

Junhee Han, Ji-Ho Park

Current Opinion in Biotechnology · 2023

DOI: 10.1016/j.copbio.2023.103014 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Opinion in Biotechnology, 2023. Verfasst von Junhee Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bio and Brain Engineering, and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (K…. Hauptthemen laut MEDLINE: Neoplasms, Cancer Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: National Research Foundation of Korea, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global adaptation of mRNA vaccines to protect against the COVID-19 pandemic was a major interdisciplinary milestone, demonstrating the potential of combining mRNA applications with nanotechnology. This innovative strategy holds great promise as an improved therapeutic modality for cancer immunotherapy, as further development could facilitate targeted mRNA delivery to specific immune cells and enable manipulation of effector functions. Toward this, researchers have made substantial efforts to modulate various immune cell types, including lymphoid organ dendritic cells for cancer vaccines, peripheral blood lymphocytes for in situ T-cell therapy, and macrophages in the tumor microenvironment to restore antitumor functions. Here, we highlight recent advances in mRNA nanoformulations for cancer immunotherapy, emphasizing strategies for target cell engagement in different immunological sites.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCancer VaccinesHumansPandemicsImmunotherapyMacrophagesNanotechnologyTumor Microenvironment

Substanzen

Cancer Vaccines

Autor:innen und Institutionen

  • Department of Bio and Brain Engineering, and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea.
  • Department of Bio and Brain Engineering, and KAIST Institute for Health Science and Technology, Korea Advanced Institute of Science and Technology (KAIST), Daejeon 34141, Republic of Korea. Electronic address: jihopark@…

Förderung

  • National Research Foundation of Korea
  • Ministry of Science, ICT and Future Planning

Zitieren

APA

Han, J., & Park, J. H. (2023). Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy. Current Opinion in Biotechnology. https://doi.org/10.1016/j.copbio.2023.103014

Vancouver

Han J, Park JH. Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy. Current Opinion in Biotechnology. 2023. doi:10.1016/j.copbio.2023.103014

BibTeX
@article{Han2023,
  author = {Han, Junhee and Park, Ji-Ho},
  title = {Modulation of immune cells with mRNA nanoformulations for cancer immunotherapy},
  journal = {Current Opinion in Biotechnology},
  year = {2023},
  doi = {10.1016/j.copbio.2023.103014}
}
Kostenlos starten →